Holen Sie sich die Stockscreener-App
2.07
1.47%
0.03
Handel nachbörslich:
2.12
0.05
+2.42%
Schlusskurs vom Vortag:
$2.04
Offen:
$2.03
24-Stunden-Volumen:
25,405
Relative Volume:
0.30
Marktkapitalisierung:
$102.46M
Einnahmen:
$63.69M
Nettoeinkommen (Verlust:
$-44.82M
KGV:
-0.8625
EPS:
-2.4
Netto-Cashflow:
$-30.56M
1W Leistung:
+2.05%
1M Leistung:
+3.50%
6M Leistung:
-34.08%
1J Leistung:
-30.77%
1-Tages-Spanne:
$2.03
$2.0899
1-Wochen-Bereich:
$2.01
$2.16
52-Wochen-Spanne:
$1.95
$4.64
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings - GuruFocus.com
Lake Street Initiates Coverage of MDxHealth (MDXH) with Buy Recommendation - MSN
MVM Partners, LLC Increases Stake in MDxHealth SA - GuruFocus.com
Liquid Biopsy Market Set for Explosive Growth by 2024-2031: Key Trends and Drivers | MDxHealth SA, Natera, Inc - EIN News
MdxHealth’s US$40 Million Ordinary Shares Offering - Global Legal Chronicle
MDxHealth stock hits 52-week low at $1.95 amid market challenges - Investing.com
Critical Analysis: MDxHealth (NASDAQ:MDXH) & Aclarion (NASDAQ:ACON) - Defense World
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6 - The Manila Times
DLA Piper advises TD Cowen as underwriter in MdxHealth’s US$40 million public offering of ordinary shares - Legal Desire News Network
Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal
MDxHealth announces pricing of registered public offering - Medical Buyer
mdxHealth stock touches 52-week low at $2.0 amid market challenges - Investing.com Australia
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.62% - MSN
MDXH’s Market Whiplash: -48.98% YTD Decline, -31.40% Plunge in 30 Days - The InvestChronicle
Dow Surges Over 250 Points; Accenture Earnings Top Views - Benzinga
MDXH’s price-to-book ratio: An indicator of the company’s performance - US Post News
Crude Oil Down Over 2%; US Initial Jobless Claims Fall - Benzinga
Prostate Cancer Diagnostics Market Advancements Highlighted by Dynamics, Industry Trends, Size & Growth - WhaTech
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket - TradingView
MDxHealth seeks $40 million through share offering - Investing.com India
MDxHealth seeks $40 million through share offering By Investing.com - Investing.com Australia
MDxHealth Announces Pricing of Offering of Ordinary Shares - 24matins.uk
MDxHealth Shares Plunge on New Offering - Orange County Business Journal
MDxHealth Announces Launch of Offering of Ordinary Shares - EIN News
MDxHealth (OTCMKTS:MXDHF) Trading Down 9.1% - Defense World
Cellular Health Screening Global Market Report Explores 2024 Insights, Forecast, Growth, Trends 2024-2033 - WhaTech
Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights - GlobeNewswire Inc.
Q3 2024 EPS Estimates for MDxHealth SA Cut by Analyst (NASDAQ:MDXH) - Defense World
MDxHealth SA (NASDAQ:MDXH) Q2 2024 Earnings Call Transcript - Insider Monkey
MDxHealth stock supported by BTIG as Q2 revenue and guidance impress - Investing.com
Earnings call: MDxHealth posts strong Q2 results, raises 2024 guidance - Investing.com
Piper Sandler reaffirms MDxHealth stock optimism, consistent revenue outperformance - Investing.com
MDxHealth Q2 2024 revenues jump 32% to USD 22.2 million - Medical Buyer
MDxHealth SA (MDXH) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Raised Guidance - GuruFocus.com
MDxHealth Reports Q2 and Half Year 2024 Results - wallstreet:online
MDXH (MDxHealth) EPS without NRI : $-1.49 (TTM As of Mar. 2024) - GuruFocus.com
MDxHealth (MDXH) Set to Announce Quarterly Earnings on Wednesday - Defense World
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21 - StockTitan
Mdxhealth appoints Sanford J. Siegel to board of directors - Medical Buyer
MDxHealth shares reiterate Buy rating on raised FY'24 revenue guidance By Investing.com - Investing.com India
MDxHealth reports preliminary Q2 and half-year 2024 revenue - Medical Buyer
MDxHealth shares reiterate Buy rating on raised FY'24 revenue guidance - Investing.com
A. O. Smith sets quarterly dividend at 32 cents per share By Investing.com - Investing.com UK
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance - StockTitan
MDxHealth (NASDAQ:MDXH) Shares Up 2.6% - Defense World
Liver Biopsy Industry Startegy Analysis} Cook Medical, Boston Scientific, Hologic, MDxHealth – Economica - Economica
Is a Surprise Coming for MDxHealth (MDXH) This Earnings Season? - Yahoo Lifestyle Singapore
MDxHealth Notice of Financial Year 2017 Results - Yahoo Lifestyle UK
MDxHealth Analytical Validation Study on AssureMDx for Bladder Cancer Published in The Journal of Urology - SelectScience
Liquid Biopsy Market Growth Developments, Strategies, Key Opportunity and Challenges Forecast to 2031 - WhaTech
Premier, Inc. (PINC) Q3 Earnings Match Estimates - Yahoo Lifestyle UK
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.48%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):